| 摘要 |
A method for treating endothelial cell dysfunction, such as associated with cardiovascular disease are disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N,N'-1,1'-((27''-ethoxy)-3'''(O)-4'''-(N,N-dimethylamino)-butane)-bis-(3,3'indolyl)]-1(H)-pyrrole-2,5-dione hydrochloride salt.
|
| 申请人 |
ELI LILLY AND COMPANY;JIROUSEK, MICHAEL, R.;HEATH, WILLIAM, FRANCIS, JR.;WAYS, DOUGLAS, KIRK;STRAMM, LAWRENCE, E. |
发明人 |
JIROUSEK, MICHAEL, R.;HEATH, WILLIAM, FRANCIS, JR.;WAYS, DOUGLAS, KIRK;STRAMM, LAWRENCE, E. |
